CHELSEA FAIRLEY: Open Payments
NPI 1265902852 · SOUTHERN PINES, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 70 payments from 14 companies in 2025. Trend: 2023 $764 · 2024 $1,854 · 2025 $1,620
Food & beverage: $1,520Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $448 |
| ABBVIE INC. | 24 | $337 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $239 |
| GENZYME CORPORATION | 4 | $103 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $97 |
| Incyte Corporation | 3 | $82 |
| UCB, Inc. | 3 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
Products named: TREMFYA, ILUMYA, SKYRIZI, DUPIXENT, RINVOQ, SILIQ, OPZELURA, Bimzelx.
Industry payments across NC — which companies pay providers there.
